Conventional and novel therapeutic options in children with familial Mediterranean fever: A rare autoinflammatory disease.

Poddighe, Dimitri; Romano, Micol; Garcia-Bournissen, Facundo; Demirkaya, Erkan

Poddighe, Dimitri; Romano, Micol; Garcia-Bournissen, Facundo; Demirkaya, Erkan.

Afiliación

Poddighe D; Department of Medicine, Nazarbayev University School of Medicine, Nur-Sultan, Kazakhstan.
Romano M; Clinical Academic Department of Pediatrics, National Research Center of Maternal and Child Health, University Medical Center, Nur-Sultan, Kazakhstan.
Garcia-Bournissen F; Schulich School of Medicine & Dentistry, Department of Pediatrics, Division of Pediatric Rheumatology, University of Western Ontario, London, ON, Canada.
Demirkaya E; Schulich School of Medicine & Dentistry, Department of Pediatrics, Canadian Behcet and Autoinflammatory Center (CAN BE AID), University of Western Ontario, London, ON, Canada.

Br J Clin Pharmacol ; 88(6): 2484-2499, 2022 06.

Article en En | MEDLINE | ID: mdl-34799863

Asunto(s)

Fiebre Mediterránea Familiar; Adulto; Niño; Colchicina/uso terapéutico; Fiebre Mediterránea Familiar/complicaciones; Fiebre Mediterránea Familiar/diagnóstico; Fiebre Mediterránea Familiar/tratamiento farmacológico; Humanos; Proteína Antagonista del Receptor de Interleucina 1/uso terapéutico

Palabras clave

EMA; FDA; anakinra; canakinumab; children; colchicine; familial Mediterranean fever; interleukin-1 antagonists; rilonacept

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fiebre Mediterránea Familiar Tipo de estudio: Diagnostic_studies Límite: Adult / Child / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google